Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Philogen SpA's Enterprise Value is €571.5 Mil.
Philogen SpA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €268.0 Mil. Therefore, Philogen SpA's EV-to-OCF for today is 2.13.
The historical rank and industry rank for Philogen SpA's EV-to-OCF or its related term are showing as below:
MIL:PHIL'
s EV-to-OCF Range Over the Past 10 Years
Min: -168.78 Med: -34.38 Max: 24.23
Current: 2.14
During the past 6 years, the highest EV-to-OCF of Philogen SpA was 24.23. The lowest was -168.78. And the median was -34.38.
MIL:PHIL's EV-to-OCF is ranked worse than 78.87% of 1410
companies
in the Biotechnology industry
Industry Median: -3.41
vs MIL:PHIL: 2.14
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Philogen SpA's PE Ratio (TTM) for today is calculated as:
Philogen SpA's share price for today is €23.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Philogen SpA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €5.700.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Philogen SpA EV-to-OCF Related Terms
Philogen SpA EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Philogen SpA's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:PHIL vs VRTX, REGN, RVMD: EV-to-OCF Comparison
For the Biotechnology subindustry, Philogen SpA's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Philogen SpA EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Philogen SpA's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Philogen SpA's EV-to-OCF falls into.
Philogen SpA's current Enterprise Value is €571.5 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Philogen SpA's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €268.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Philogen SpA (MIL:PHIL) has a EV-to-OCF of 2.13 as of Aug. 06, 2026. According to the industry distribution chart, Philogen SpA ranks #1112 out of 1410 companies in the Biotechnology industry, placing it in the top 78.9%.
Is Philogen SpA's EV-to-OCF too high?
Philogen SpA's current EV-to-OCF is 2.13. Based on the distribution chart, Philogen SpA ranks #1112 out of 1410 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Philogen SpA has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Philogen SpA's EV-to-OCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Philogen SpA ranks #1112 out of 1410 companies for EV-to-OCF. This places Philogen SpA in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Philogen SpA's current EV-to-OCF is 2.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Philogen SpA stock overvalued right now?
Based on GuruFocus' analysis, Philogen SpA (MIL:PHIL) is currently considered Possible Value Trap. The stock's GF Value™ is €231.87, compared to a current price of €23.35 — trading 89.9% below its estimated fair value. The current EV-to-OCF is 2.13. Philogen SpA's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Philogen SpA (MIL:PHIL), the current EV-to-OCF is 2.13 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Philogen SpA (MIL:PHIL) Overvalued in 2026?
Based on GuruFocus' analysis, Philogen SpA stock appears to be undervalued.
The current stock price of €23.35 is trading 89.9% below its estimated GF Value™ of €231.87.
GuruFocus considers Philogen SpA to be Possible Value Trap.
Key valuation signals for MIL:PHIL:
EV-to-OCF: 2.13
GF Value™: €231.87 vs. price of €23.35 (89.9% below fair value)
No single metric tells the full story. See the MIL:PHIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
50GF Score
Get the complete analysis for MIL:PHIL
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PHIL has been successfully added to your 
